Kinetic investigation of chemokine truncation by CD26/dipeptidyl peptidase IV reveals a striking selectivity within the chemokine family

被引:234
作者
Lambeir, AM
Proost, P
Durinx, C
Bal, G
Senten, K
Augustyns, K
Scharpé, S
Van Damme, J
De Meester, I
机构
[1] Univ Antwerp, Med Biochem Lab, Dept Pharmaceut Sci, B-2610 Antwerp, Belgium
[2] Katholieke Univ Leuven, Rega Inst Med Res, Lab Mol Immunol, B-3000 Louvain, Belgium
[3] Univ Antwerp, Dept Pharmaceut Sci, Med Chem Lab, B-2610 Antwerp, Belgium
关键词
D O I
10.1074/jbc.M103106200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Chemokines coordinate many aspects of leukocyte migration. As chemoattractants they play an important role in the innate and acquired immune response. There is good experimental evidence that N-terminal truncation by secreted or cell surface proteases is a way of modulating chemokine action. The localization of CD26/dipeptidyl peptidase IV on cell surfaces and in biological fluids, its primary specificity, and the type of naturally occurring truncated chemokines are consistent with such a function. We determined the steady-state catalytic parameters for a relevant selection of chemokines (CCL3b, CCL5, CCL11, CCL22, CXCL9, CXCL10, CXCL11, and CXCL12) previously reported to alter their chemotactic behavior due to CD26/dipeptidyl peptidase IV-catalyzed truncation. The results reveal a striking selectivity for stromal cell-derived factor-la (CXCL12) and macrophage-derived chemokine (CCL22). The kinetic parameters support the hypothesis that CD26/dipeptidyl peptidase IV contributes to the degradation of certain chemokines in vivo. The data not only provide insight into the selectivity of the enzyme for specific chemokines, but they also contribute to the general understanding of CD26/dipeptidyl peptidase IV secondary substrate specificity.
引用
收藏
页码:29839 / 29845
页数:7
相关论文
共 62 条
  • [11] 2-6
  • [12] Use of immobilized adenosine deaminase (EC 3.5.4.4) for the rapid purification of native human CD26 dipeptidyl peptidase IV (EC 3.4.14.5)
    DeMeester, I
    Vanhoof, G
    Lambeir, AM
    Scharpe, S
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1996, 189 (01) : 99 - 105
  • [13] COSTIMULATION OF CD4(+) AND CD8(+) T-CELLS THROUGH CD26 - THE ADA-BINDING EPITOPE IS NOT ESSENTIAL FOR COMPLETE SIGNALING
    DEMEESTER, IA
    KESTENS, LL
    VANHAM, GL
    VANHOOF, GC
    VINGERHOETS, JH
    GIGASE, PL
    SCHARPE, SL
    [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 1995, 58 (03) : 325 - 330
  • [14] Molecular characterization of dipeptidyl peptidase activity in serum -: Soluble CD26/dipeptidyl peptidase IV is responsible for the release of X-Pro dipeptides
    Durinx, C
    Lambeir, AM
    Bosmans, E
    Falmagne, JB
    Berghmans, R
    Haemers, A
    Scharpé, S
    De Meester, I
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 2000, 267 (17): : 5608 - 5613
  • [15] Structures of prolyl oligopeptidase substrate/inhibitor complexes -: Use of inhibitor binding for titration of the catalytic histidine residue
    Fülöp, V
    Szeltner, Z
    Renner, V
    Polgár, L
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (02) : 1262 - 1266
  • [16] The role of chemokines in human immunodeficiency virus infection
    Garzino-Demo, A
    DeVico, AL
    Conant, KE
    Gallo, RC
    [J]. IMMUNOLOGICAL REVIEWS, 2000, 177 : 79 - 87
  • [17] Molecular analysis of CD26-mediated signal transduction in T cells
    Hühn, J
    Ehrlich, S
    Fleischer, B
    von Bonin, A
    [J]. IMMUNOLOGY LETTERS, 2000, 72 (02) : 127 - 132
  • [18] CD26/dipeptidyl peptidase IV differentially regulates the chemotaxis of T cells and monocytes toward RANTES: possible mechanism for the switch from innate to acquired immune response
    Iwata, S
    Yamaguchi, N
    Munakata, Y
    Ikushima, H
    Lee, JF
    Hosono, O
    Schlossman, SF
    Morimoto, C
    [J]. INTERNATIONAL IMMUNOLOGY, 1999, 11 (03) : 417 - 426
  • [19] Kähne T, 1999, INT J MOL MED, V4, P3
  • [20] Chemokines, cytokines and HIV: a complex network of interactions that influence HIV pathogenesis
    Kinter, A
    Arthos, J
    Cicala, C
    Fauci, AS
    [J]. IMMUNOLOGICAL REVIEWS, 2000, 177 : 88 - 98